261 related articles for article (PubMed ID: 27634616)
1. Constitutively active Stat5b signaling confers tolerogenic functions to dendritic cells of NOD mice and halts diabetes progression.
Zerif E; Maalem A; Gaudreau S; Guindi C; Ramzan M; Véroneau S; Gris D; Stankova J; Rola-Pleszczynski M; Mourad W; Dupuis G; Amrani A
J Autoimmun; 2017 Jan; 76():63-74. PubMed ID: 27634616
[TBL] [Abstract][Full Text] [Related]
2. Elucidating the Role of Ezh2 in Tolerogenic Function of NOD Bone Marrow-Derived Dendritic Cells Expressing Constitutively Active Stat5b.
Zerif E; Khan FU; Raki AA; Lullier V; Gris D; Dupuis G; Amrani A
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899608
[TBL] [Abstract][Full Text] [Related]
3. Stat5b/Ezh2 axis governs high PD-L1 expressing tolerogenic dendritic cell subset in autoimmune diabetes.
Ullah Khan F; Khongorzul P; Gris D; Amrani A
Int Immunopharmacol; 2024 May; 133():112166. PubMed ID: 38678673
[TBL] [Abstract][Full Text] [Related]
4. Granulocyte-macrophage colony-stimulating factor prevents diabetes development in NOD mice by inducing tolerogenic dendritic cells that sustain the suppressive function of CD4+CD25+ regulatory T cells.
Gaudreau S; Guindi C; Ménard M; Besin G; Dupuis G; Amrani A
J Immunol; 2007 Sep; 179(6):3638-47. PubMed ID: 17785799
[TBL] [Abstract][Full Text] [Related]
5. Total coumarins from Urtica dentata Hand prevent murine autoimmune diabetes via suppression of the TLR4-signaling pathways.
Wang J; Lu J; Lan Y; Zhou H; Li W; Xiang M
J Ethnopharmacol; 2013 Mar; 146(1):379-92. PubMed ID: 23340441
[TBL] [Abstract][Full Text] [Related]
6. Thymic stromal lymphopoietin and thymic stromal lymphopoietin-conditioned dendritic cells induce regulatory T-cell differentiation and protection of NOD mice against diabetes.
Besin G; Gaudreau S; Ménard M; Guindi C; Dupuis G; Amrani A
Diabetes; 2008 Aug; 57(8):2107-17. PubMed ID: 18477807
[TBL] [Abstract][Full Text] [Related]
7. Over-expression of Stat5b confers protection against diabetes in the non-obese diabetic (NOD) mice via up-regulation of CD4(+)CD25(+) regulatory T cells.
Jin Y; Purohit S; Chen X; Yi B; She JX
Biochem Biophys Res Commun; 2012 Aug; 424(4):669-74. PubMed ID: 22789848
[TBL] [Abstract][Full Text] [Related]
8. Antisense oligonucleotides down-regulating costimulation confer diabetes-preventive properties to nonobese diabetic mouse dendritic cells.
Machen J; Harnaha J; Lakomy R; Styche A; Trucco M; Giannoukakis N
J Immunol; 2004 Oct; 173(7):4331-41. PubMed ID: 15383562
[TBL] [Abstract][Full Text] [Related]
9. Immature Dendritic Cell Therapy Confers Durable Immune Modulation in an Antigen-Dependent and Antigen-Independent Manner in Nonobese Diabetic Mice.
Lo J; Xia CQ; Peng R; Clare-Salzler MJ
J Immunol Res; 2018; 2018():5463879. PubMed ID: 29651443
[TBL] [Abstract][Full Text] [Related]
10. Treatment with granulocyte colony-stimulating factor prevents diabetes in NOD mice by recruiting plasmacytoid dendritic cells and functional CD4(+)CD25(+) regulatory T-cells.
Kared H; Masson A; Adle-Biassette H; Bach JF; Chatenoud L; Zavala F
Diabetes; 2005 Jan; 54(1):78-84. PubMed ID: 15616013
[TBL] [Abstract][Full Text] [Related]
11. Antigen Loading (e.g., Glutamic Acid Decarboxylase 65) of Tolerogenic DCs (tolDCs) Reduces Their Capacity to Prevent Diabetes in the Non-Obese Diabetes (NOD)-Severe Combined Immunodeficiency Model of Adoptive Cotransfer of Diabetes As Well As in NOD Mice.
Funda DP; Goliáš J; Hudcovic T; Kozáková H; Špíšek R; Palová-Jelínková L
Front Immunol; 2018; 9():290. PubMed ID: 29503651
[TBL] [Abstract][Full Text] [Related]
12. Despite Increased Type 1 IFN, Autoimmune Nonobese Diabetic Mice Display Impaired Dendritic Cell Response to CpG and Decreased Nuclear Localization of IFN-Activated STAT1.
Rahman MJ; Rahir G; Dong MB; Zhao Y; Rodrigues KB; Hotta-Iwamura C; Chen Y; Guerrero A; Tarbell KV
J Immunol; 2016 Mar; 196(5):2031-40. PubMed ID: 26826238
[TBL] [Abstract][Full Text] [Related]
13. Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells.
Mellanby RJ; Thomas D; Phillips JM; Cooke A
Immunology; 2007 May; 121(1):15-28. PubMed ID: 17428252
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of Foxp3 expression in mouse and human Treg is IL-2/STAT5 dependent: implications for the NOD STAT5B mutation in diabetes pathogenesis.
Murawski MR; Litherland SA; Clare-Salzler MJ; Davoodi-Semiromi A
Ann N Y Acad Sci; 2006 Oct; 1079():198-204. PubMed ID: 17130555
[TBL] [Abstract][Full Text] [Related]
15. CCL22-producing CD8α- myeloid dendritic cells mediate regulatory T cell recruitment in response to G-CSF treatment.
Layseca-Espinosa E; Korniotis S; Montandon R; Gras C; Bouillié M; Gonzalez-Amaro R; Dy M; Zavala F
J Immunol; 2013 Sep; 191(5):2266-72. PubMed ID: 23878314
[TBL] [Abstract][Full Text] [Related]
16. CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes.
Tarbell KV; Yamazaki S; Olson K; Toy P; Steinman RM
J Exp Med; 2004 Jun; 199(11):1467-77. PubMed ID: 15184500
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoid-induced leucine zipper enhanced expression in dendritic cells is sufficient to drive regulatory T cells expansion in vivo.
Calmette J; Ellouze M; Tran T; Karaki S; Ronin E; Capel F; Pallardy M; Bachelerie F; Krzysiek R; Emilie D; Schlecht-Louf G; Godot V
J Immunol; 2014 Dec; 193(12):5863-72. PubMed ID: 25362183
[TBL] [Abstract][Full Text] [Related]
18. Reduced numbers of dendritic cells with a tolerogenic phenotype in the prediabetic pancreas of NOD mice.
Welzen-Coppens JM; van Helden-Meeuwsen CG; Leenen PJ; Drexhage HA; Versnel MA
J Leukoc Biol; 2012 Dec; 92(6):1207-13. PubMed ID: 23012431
[TBL] [Abstract][Full Text] [Related]
19. Induction of Tolerogenic Dendritic Cells by a PEGylated TLR7 Ligand for Treatment of Type 1 Diabetes.
Hayashi T; Yao S; Crain B; Promessi VJ; Shyu L; Sheng C; Kang M; Cottam HB; Carson DA; Corr M
PLoS One; 2015; 10(6):e0129867. PubMed ID: 26076454
[TBL] [Abstract][Full Text] [Related]
20. Insulin administration confers diabetes-preventive properties to NOD mice derived dendritic cells.
Xiang M; Zou X; Zhang C; Zhao Z; Xu J
Immunopharmacol Immunotoxicol; 2007; 29(3-4):451-64. PubMed ID: 18075857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
